4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-121742
Chief Development Officer sold 10,000 shares at $48.97 ($489,700)
- Chief Development Officer acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2024-11-01 | Option exercise 10b5-1 | +6,606 | $21.65 | $143,020 | 12,402 | D: show line 1 in the form |
| Guyer William Chief Development Officer | 2024-11-01 | Sale 10b5-1 | −6,606 | $48.97 | $323,496 | 5,796 | D: show line 2 in the form |
| Guyer William Chief Development Officer | 2024-11-04 | Option exercise 10b5-1 | +3,394 | $21.65 | $73,480 | 9,190 | D: show line 3 in the form |
| Guyer William Chief Development Officer | 2024-11-04 | Sale 10b5-1 | −3,394 | $48.97 | $166,204 | 5,796 | D: show line 4 in the form |
| Open-market sales · 10,000 sh · avg $48.97 · $489,700 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2024-11-01 | Option exercise · Stock option (right to buy) 10b5-1 | −6,606 | 453,394 | D: show line 5 in the form | |||||
| Guyer William Chief Development Officer | 2024-11-04 | Option exercise · Stock option (right to buy) 10b5-1 | −3,394 | 450,000 | D: show line 6 in the form |
Loading xslF345X05/ownership.xml…